Biostorage: Closing the Loop in Biopharmaceutical Supply Chain Management

January 03, 2017 The complexity of shipping and storing temperature-sensitive biologics creates cold chain challenges. However, these risks can be mitigated when advanced packaging, data monitoring and biostorage...

IT and Logistics Solutions for Animal Vaccine Distribution

December 07, 2016

Animal vaccines are essential, not just because they can effectively prevent potentially serious diseases in animals, but also they can be beneficial to humans’ health. In an International Journal...

Cold Chain Planning: An Integrated Approach

December 03, 2016

CAR T-cell therapy, immunotherapy and other autologous cellular therapies require an integrated approach for their manufacture, shipment and storage. The need for integration is largely due to the...

Logistics Advancements and Trends in the Biopharma Industry

December 01, 2016

For successful commercial distribution, advanced cellular therapies require secure, well-designed cold chain management solutions based on effective packaging, informatics and logistics expertise....

Cold Chain Challenges Evolving With Industry

November 23, 2016

To ensure the safety and efficacy of inherently fragile regenerative medicines and other temperature-sensitive clinical trial therapeutics and biospecimens, the materials must be maintained within...

Cold Chain Planning for Regenerative Medicine Clinical Studies

November 01, 2016

The advent of regenerative therapy — a field that includes gene therapy, gene editing, stem cell therapy and immuno-oncology — is creating an unprecedented need for cold chain logistics. According...

It’s Never Too Early for Cold Chain Planning for Cellular Therapies

October 01, 2016 New cellular therapies underscore the complexity of cold chain logistics with new requirements that may be unfamiliar to even experienced supply chain managers. Writing in Applied Clinical Trials,

The Complexity of Cold Chain Logistics

September 08, 2016 Cell and gene therapy is now considered “the third pillar” of health care — along with traditional pharmaceuticals and biologic drugs. One critical challenge in the commercialization of cell and...

Cryoport Launching Logistics Study for Bioanalytical and Clinical Trial Materials

August 30, 2016 Cryoport launched a study examining the effects of temperature and transport packaging on biomarkers and cell-therapy cancer vaccines. Currently, little research has examined shipping conditions’...

CenterWatch Interview: Cryoport’s Chief Commercial Officer, Mark W. Sawicki, Ph.D., on a New Era of Logistics Challenges

August 22, 2016 Logistics, and particularly cold chain logistics, has taken an increasingly important role in the development of new therapeutics. With the advent of regenerative medicines and personalized...

Cryoport to Convert Life Science Shipping Logistics For Contract Manufacturer

August 06, 2016 Cryoport continues to grow with the recent signing of an agreement with a leading contract biopharmaceutical supplier to convert its current fleet of liquid nitrogen (LN2) dewars to Cryoport’s...

Supply Chain Challenges with New Therapies

July 07, 2016

Supply chains for many regenerative therapies can be very complex. Where traditional pharmaceuticals have linear supply chain models, autologous cell therapies oftentimes require circular supply...

The Best Chance of Delivery for Life-Giving Shipments

June 21, 2016

As Asia’s pharmaceutical and biopharmaceutical industries grow, the infrastructure, supply chain management and logistics management challenges necessitate innovation. The need for proper shipping...

Cryogenic Gas Solutions Drive Regenerative Therapies in Life Sciences

June 06, 2016

Innovation in the pharmaceutical industry is being led by regenerative therapies. Many of these new therapies need to be maintained at cryogenic conditions during storage and transport and cannot...

Logistical Nightmare

May 10, 2016 Today’s most innovative medical breakthroughs, including cell therapies, tissue engineering, gene-modified cell therapies and genome editing therapies have three things in common: They are...

Consequences of Using Non-Frozen Delivery Systems Putting Biopharmaceutical Cargo at Risk

May 09, 2016

Non-frozen delivery systems for new drug therapies do not always provide acceptable temperature control. In the event of a transportation delay, medicines that require strict temperature...

Inside the Hidden Global Supply Chain for Frozen Sperm, Eggs and Embryos

April 25, 2016

Having a baby through IVF can be a global endeavor. With the eggs, sperm and surrogate each potentially coming from a different country, the role of the cold chain has never been more important....

Cold Chain: Going the Extra Mile

February 01, 2016 Changing global regulatory requirements and complex supply chains have resulted in increasingly conservative approaches to temperature control in biopharmaceutical logistics. Cryoport Chief...

How Cold Chain Logistics Work in Clinical Trials

November 17, 2015 In this exclusive article for Applied Clinical Trials, Cryoport Chief Commercial Officer Mark Sawicki, Ph.D. , discusses the importance of reliable, environmentally controlled cold chain...

Cryogenic Cold Chain Risk Mitigation

November 13, 2015 In an interview with Contract Pharma, Cryoport Chief Commercial Officer Mark Sawicki, Ph.D. , explains the requirements, challenges and regulatory issues associated with cryogenically shipping...

Shipping Service Offers Cryogenic Transit and Storage

November 14, 2014 Through UPS’ Temperature True® Cryo service, UPS is broadening its temperature-sensitive shipping offerings to include cryogenic solutions for UPS health care customers by utilizing Cryoport’s...